Scholar Rock Holding Corporation (NASDAQ:SRRK) headquartered in Cambridge, will host a conference call for the investment community to discuss the 2Q20 financial results on 7th August 2020 at 8:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.scholarrock.com
Earnings Expectation
Scholar Rock Holding Corporation is set to announce second quarter earning results on Friday 7th August 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, SRRK to report 2Q20 loss of $ 0.54 per share. For the full year, analysts anticipate top line of $ 25.48 million, while looking forward to loss of $ 2.18 per share bottom line.
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, an inhibitor of the activation of myostatin, which is in Phase I clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, an inhibitor of the activation of transforming growth factor beta-1 to treat cancers resistant to checkpoint blockade therapies.
